86 021-5169 5932 

新闻中心
2023 - 08 / 26

Polymersomes for protein drug delivery across intestinal mucosa

日期: 2023-08-26
浏览次数: 549

The oral administration is the route preferred by patients due to its multiple advantages. In the case of biopharmaceuticals, due to their low stability and absorption in the intestine, these molecules must be administered by injectable routes. To circumvent these problems, several strategies have been studied, among which the use of nanosystems, such as polymersomes, can be highlighted.

In this work the potential of poloxamer 401 polymersomes as a system for oral delivery of antibodies was evaluated. IgG-FITC-loaded poloxamer 401 polymerosomes were initially used to assess whether it improves intestinal epithelial permeation in Caco-2 cell monolayers. Subsequently, epithelial/macrophage co-culture model was used to evaluate the ability of poloxamer 401 polymersomes containing adalimumab to reduce proinflammatory cytokine levels.

The data showed that polymersome-encapsulated IgG increased the transport across intestinal Caco-2 monolayers 2.7-fold compared to the antibody in solution. Also, when comparing the groups of blank polymersomes with polymersomes containing adalimumab, decreases of 1.5-, 5.5-, and 2.4-fold in TNF-α concentrations were observed for the polymersomes containing 1.5, 3.75, and 15 µg/mL of adalimumab, respectively. This could indicate a possibility for the oral administration of biopharmaceuticals which would revolutionize many conditions that require the systemic administration such as in inflammatory bowel disease.

Read more here

Jorge Javier Muso-Cachumba, Sa Feng, Mona Belaid, Yunyue Zhang, Carlota de Oliveira Rangel-Yagui, Driton Vllasaliu, Polymersomes for protein drug delivery across intestinal mucosa, International Journal of Pharmaceutics.

Related news / Breaking news
2023 - 08 - 26
点击次数: 549
The oral administration is the route preferred by patients due to its multiple advantages. In the case of biopharmaceuticals, due to their low stability and absorption in the intestine, these molecule...
2023 - 04 - 12
点击次数: 5785
Discover how the pharmaceutical workforce has evolved past the pandemic, and the challenges faced by the pharma industry during a talent acquisition and retention crisis. While speaking of pharma...
2023 - 05 - 10
点击次数: 6661
The collaboration between the pharmaceutical giant and scientific technology provider will aim to bring rapid and localised services to areas around the globe that lack affordable advanced genomic tes...
2023 - 07 - 06
点击次数: 2684
CPHI & PMEC China will open a special roadshow to be hosted at the PWTC Expo (4-6 September, 2023) in the city of Guangzhou (Guangdong Province).The new addition to this year’s CPHI...
回到顶部
      RonPharm Corp.
Copyright ©2013 - 2023 RonPharm Corp.
Serviced by RonCloud
Serviced by RonCloud
4-4F, Pujiang Building, Business Road, Kunshan, Jiangsu, China
Tel : 86 021-5169 5932
            Fax : 86 021-5168 5270
邮编:330520